Vitrolife AB (Publ): Conference Call Interim Report

Regulatory News:

Invitation to attend Vitrolife’s (STO:VITR) conference call regarding presentation of the interim report for the period January – March 2016. The presentation will be held in English.

Time: Tuesday April 26, 2016 at 10.00 a.m. CET.

Registration can preferably be done 10-15 minutes before the conference start time on: Sweden dial in number: +46 (0)8 5052 0114 UK dial in number: +44 (0)207 1620 177 Conference name: Vitrolife, conference ID: 958436

Vitrolife participants:

Thomas Axelsson, CEO

Mikael Engblom, CFO

The press release for Vitrolife’s interim report will be released at 8.30 CET on the same day.

Before the conference call, slides will be available at the company web page, http://www.vitrolife.com (http://www.vitrolife.com/en/Corporate/)

A recorded version of the presentation will be available for seven days on number +46 (0)8 5052 0333 (Sweden) or 020 7031 4064 (UK), access code 958436.

Gothenburg, April 18, 2016 VITROLIFE AB (publ)

Vitrolife is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on April 18, 2016 at 1:00 p.m.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

_________________________________________________________________________________________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes

Vitrolife has approximately 330 employees and the company's products are sold in almost 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm, Mid Cap.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160418005772/en/